ThermoGenesis

Cesca Therapeutics (NASDAQ: KOOL) shares spiked higher after the company's subsidiary, ThermoGenesis, received Health Canada approval for its AXP II System for cord blood processing. "Health Canada's approval of the AXP II -- following its approval of the PXP System earlier this year...